Zimmer Biomet Holdings (ZBH) reported Q4 adjusted earnings Thursday of $2.31 per diluted share, up from $2.20 a year earlier.
One analyst polled by FactSet expected $1.73.
Net sales for the quarter ended Dec. 31 were $2.02 billion, up from $1.94 billion a year earlier.
Analysts surveyed by FactSet expected $2.01 billion.
The company said it expects 2025 adjusted earnings of $8.15 to $8.35 per diluted share, with revenue growing by 1.0% to 3.5%.
Two analysts surveyed by FactSet expect 2025 adjusted EPS of $7.43.
Zimmer Biomet shares were down by more than 2% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。